134 related articles for article (PubMed ID: 29104001)
1. Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent?
Parikh KH; Kirtane AJ
Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):416-417. PubMed ID: 29104001
[No Abstract] [Full Text] [Related]
2. Impact of statin non-adherence on in-stent restenosis following bare-metal stent implantation.
Kocas C; Abaci O; Kocas BB; Cetinkal G; Arslan S; Yildiz A; Ersanli M
Int J Cardiol; 2016 Jan; 203():529-31. PubMed ID: 26569357
[No Abstract] [Full Text] [Related]
3. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
[TBL] [Abstract][Full Text] [Related]
5. Blockade of mTOR pathway inhibition in the neointimal hyperplasia and promoting macrophage autophagy - Effect of statin-eluting stents to reduce in-stent restenosis.
Hu HJ; Zhou SH; Liu QM
Int J Cardiol; 2015; 187():31-2. PubMed ID: 25828306
[No Abstract] [Full Text] [Related]
6. Impact of statin therapy on late target lesion revascularization after sirolimus-eluting stent implantation (from the CREDO-Kyoto Registry Cohort-2).
Natsuaki M; Nakagawa Y; Morimoto T; Ono K; Shizuta S; Furukawa Y; Kadota K; Iwabuchi M; Kato Y; Suwa S; Inada T; Doi O; Takizawa A; Nobuyoshi M; Kita T; Kimura T;
Am J Cardiol; 2012 May; 109(10):1387-96. PubMed ID: 22381164
[TBL] [Abstract][Full Text] [Related]
7. Do statins have a role in reduction/prevention of post-PCI restenosis?
Prasad K
Cardiovasc Ther; 2013 Feb; 31(1):12-26. PubMed ID: 21967674
[TBL] [Abstract][Full Text] [Related]
8. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
[TBL] [Abstract][Full Text] [Related]
9. Bioresorbable Stents in PCI.
Lindholm D; James S
Curr Cardiol Rep; 2016 Aug; 18(8):74. PubMed ID: 27312934
[TBL] [Abstract][Full Text] [Related]
10. Evolving management of patients treated by drug-eluting stent: prevention of late events.
Niccoli G; Sgueglia GA; Montone RA; Roberto M; Banning AP; Crea F
Cardiovasc Revasc Med; 2014 Mar; 15(2):100-8. PubMed ID: 24603193
[TBL] [Abstract][Full Text] [Related]
11. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study.
Otsuki H; Yamaguchi J; Kamishima K; Arashi H; Hagiwara N
Heart Vessels; 2018 Sep; 33(9):986-996. PubMed ID: 29549436
[TBL] [Abstract][Full Text] [Related]
12. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.
Silber S; Windecker S; Vranckx P; Serruys PW;
Lancet; 2011 Apr; 377(9773):1241-7. PubMed ID: 21459430
[TBL] [Abstract][Full Text] [Related]
13. Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
Valgimigli M; Patialiakas A; Thury A; McFadden E; Colangelo S; Campo G; Tebaldi M; Ungi I; Tondi S; Roffi M; Menozzi A; de Cesare N; Garbo R; Meliga E; Testa L; Gabriel HM; Airoldi F; Ferlini M; Liistro F; Dellavalle A; Vranckx P; Briguori C;
J Am Coll Cardiol; 2015 Mar; 65(8):805-815. PubMed ID: 25720624
[TBL] [Abstract][Full Text] [Related]
14. A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds.
Waksman R
Cleve Clin J Med; 2017 Dec; 84(12 Suppl 4):e20-e24. PubMed ID: 29281608
[TBL] [Abstract][Full Text] [Related]
15. Impact of the stent length on long-term clinical outcomes following newer-generation drug-eluting stent implantation.
Choi IJ; Koh YS; Lim S; Kim JJ; Chang M; Kang M; Hwang BH; Kim CJ; Kim TH; Seo SM; Shin DI; Park MW; Choi YS; Park HJ; Her SH; Kim DB; Kim PJ; Lee JM; Park CS; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Seung KB
Am J Cardiol; 2014 Feb; 113(3):457-64. PubMed ID: 24332246
[TBL] [Abstract][Full Text] [Related]
16. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
[TBL] [Abstract][Full Text] [Related]
17. Coated stents: a novel approach to prevent in-stent restenosis.
Curcio A; Torella D; Coppola C; Mongiardo A; Cireddu M; Falco M; Chiariello M; Indolfi C
Ital Heart J; 2002 Jun; 3 Suppl 4():16S-19S. PubMed ID: 12116820
[No Abstract] [Full Text] [Related]
18. Effect of High-Dose Statin Therapy on Drug-Eluting Stent Strut Coverage.
Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2460-7. PubMed ID: 26359512
[TBL] [Abstract][Full Text] [Related]
19. Statins and prevention of stent-related late adverse events.
Uemura S
Coron Artery Dis; 2014 Jun; 25(4):277-8. PubMed ID: 24710353
[No Abstract] [Full Text] [Related]
20. Stent selection and antiplatelet therapy duration: one size does not fit all.
Kandzari DE
J Am Coll Cardiol; 2015 Mar; 65(8):816-819. PubMed ID: 25720625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
